GLP1 medications are here to stay; K.U. endocrinologist says
Millions of people are using or have used GLP1 drugs including Ozempic, Wegovy and Mounjaro to combat diabetes and obesity.
Search fresh public links, source activity, and post angles for Glp‑1 Medications.
Fresh curated links around GLP‑1 medications are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Millions of people are using or have used GLP1 drugs including Ozempic, Wegovy and Mounjaro to combat diabetes and obesity.
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...
Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.
What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
NEW ORLEANS — Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a rang...
GLP-1 medications are an effective tool for many people’s weight loss journey, and they have changed the conversation around obesity, diabetes, and chronic disease. For many Americ...
GLP-1 medications are an effective tool for many people’s weight loss journey, and they have changed the conversation around obesity, diabetes, and chronic disease. For many Americ...
New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.
The different medications work to help regulate appetite and blood sugar levels.
While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly.
Patients can take advantage of the GLP-1 management program through their One Medical primary care clinician. Medications are available for quick delivery to all 50 states, with ne...
By Dr. Lynn WebsterIn Greek mythology, the goddess Panacea carried a potion that could heal any disease. It’s a seductive image, and it’s how GLP-1 drugs can start to feel as repor...
The use of GLP-1 medications for weight loss has skyrocketed, but there are side effects.
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...
The growing adoption of GLP-1 medications has already begun to transform society and industry sectors, along with helping many patients effectively deal with managing diabetes and...
This month’s Healio Exclusive in Healio Gastroenterology poses a highly topical question.GLP-1 receptor agonists have revolutionized the treatment of obesity and related conditions...
About 1 in 8 U.S. adults say they are taking a GLP-1 drug, according to a recent survey.
This month’s Healio Exclusive in Healio Gastroenterology poses a highly topical question.GLP-1 receptor agonists have revolutionized the treatment of obesity and related conditions...
GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...
Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data publis...
WEDNESDAY, May 13, 2026 — Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors...
CHICAGO — Patients with obesity and inflammatory bowel disease showed improved bowel function while receiving GLP-1 receptor agonists and lifestyle counseling, in contrast to the g...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.